Option Care Health, Inc.
OPCH
Rangering i aksjer
#3626
Option Care Health, Inc. delivers infusion services to patients in their homes... Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
Aksjekurs
$31.22
Sist synkronisert: 2026-10-19
Markedsverdi
$4.68B
Endring (1 dag)
0.06%
Endring (1 år)
10.01%
Land
US
Handel Option Care Health, Inc. (OPCH)
Kategori
Healthcare
Inntekter for Option Care Health, Inc. (OPCH)
Inntekter i Jun 2026 TTM: $285.47M
Ifølge Option Care Health, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat $285.47M. I 2023 hadde selskapet et resultat på $358.74M, en økning sammenlignet med resultatet i 2022, som var $205.77M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Option Care Health, Inc. fra 2000 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $285.47M | 0.66% |
| 2024 | $283.60M | -20.95% |
| 2023 | $358.74M | 74.34% |
| 2022 | $205.77M | 76.63% |
| 2021 | $116.49M | -2,321.90% |
| 2020 | $-5.24M | -93.29% |
| 2019 | $-78.19M | 791.81% |
| 2018 | $-8.77M | -87.00% |
| 2017 | $-67.43M | 97.42% |
| 2016 | $-34.16M | -89.53% |
| 2015 | $-326.35M | 135.25% |
| 2014 | $-138.73M | 97.11% |
| 2013 | $-70.38M | 262.94% |
| 2012 | $-19.39M | -176,390.91% |
| 2011 | $11.00K | -100.06% |
| 2010 | $-18.98M | -240.08% |
| 2009 | $13.55M | -115.71% |
| 2008 | $-86.23M | -1,645.03% |
| 2007 | $5.58M | -128.98% |
| 2006 | $-19.26M | -34.92% |
| 2005 | $-29.60M | -357.66% |
| 2004 | $11.49M | -24.52% |
| 2003 | $15.22M | -34.85% |
| 2002 | $23.36M | 54.33% |
| 2001 | $15.13M | -983.48% |
| 2000 | $-1.71M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| $9.87B | 3,357.77% |
US
|
|
| - | - |
DE
|
|
| $3.87B | 1,253.89% |
US
|
|
| $687.82M | 140.94% |
SA
|
|
| $1.25B | 336.72% |
BR
|
